Medicines

WHO says toxic syrup risk ‘ongoing’, more countries hit

By Jennifer Rigby LONDON, June 16 (Reuters) - There is an ongoing global threat posed by toxic cough syrups, the World Health Organization (WHO) told Reuters, saying it was now…

Read More Here

European Doctors and Pharmacists wants stronger laws to prevent medicine shortages

As patients throughout the content struggling to find antibiotics and other medicines, particularly for children, doctors and pharmacists have called on the European Commission to deliver stronger legislation to prevent…

Read More Here

EU drug regulator must do more to tackle medicine shortages – patient orgs

The European Union drug regulator needs to do more to tackle shortages of some widely-used antibiotics in the region, according to a letter from a group of European patient and…

Read More Here

No laughing matter: report shows rise in recreational use of nitrous oxide

A rise in the supply and recreational use of nitrous oxide (‘laughing gas’) is the focus of a new report by the EU drugs agency (EMCDDA). The publication points to…

Read More Here

Pfizer to sell all its drugs in low-income countries at non-profit price

U.S. drugmaker Pfizer Inc PFE.N said on Tuesday it will offer its full portfolio of drugs, including off-patent medicines such as chemotherapies and oral cancer treatments, on a not-for-profit basis to 45…

Read More Here

EU regulator set to rule on Pfizer COVID pill by end-Jan

The European Union's drug regulator is set to decide whether to approve Pfizer's COVID-19 pill at the end of this month, before doing a final review of Merck's similar but less effective drug in February, a…

Read More Here

Northern Ireland set to lose access to 2,000 medicines – FT

About 2,000 medicines currently offered to patients in Northern Ireland and made in Great Britain are set to be withdrawn as drugs manufacturers grapple with onerous post-Brexit red tape, the…

Read More Here

EU seeks to bypass patents to boost drugs access in crises

The European Union is planning bold measures to boost its access to drugs, from sidestepping patent rights in emergencies to offering incentives for companies to shift production to Europe, according…

Read More Here

First Covid-19 vaccine could be available by year-end, says EU Medicines regulator

European regulators could approve the first vaccine against Covid-19 this year, after a flurry of trials by pharma companies leading the race showed promising results, Bloomberg said. The portal quotes…

Read More Here

EU must step up efforts to tackle medicine shortages – EP

In a report on the shortage of medicines, adopted by 79 votes to 1, the Environment, Public Health and Food Safety Committee of the European Parlaiment addressed the root…

Read More Here

EU Commission coordinating supply of vital medicines to treat coronavirus patients

The Commission has initiated the coordination of European efforts to ensure that Europeans have access to essential medicines during the coronavirus outbreak. The pandemic has highlighted significant challenges in ensuring…

Read More Here

Coronavirus outbreak might lead to problems for Europe’s medicines supply

At this moment, the novel coronavirus outbreak isn’t causing problems for Europe’s medicines supply. But that’s almost certain to change, industry experts warn — and at the worst possible time…

Read More Here

Dutch health officials take measures to ensure critical drugs supplied by Britain are still supplied in case of no-Deal Brexit

Dutch health officials are rushing to ensure “critical” drugs supplied by Britain are still available if the UK crashes out of the European Union without a deal next month. The…

Read More Here

Medicines will be prioritised over food imports under No-Deal Brexit

Medicines will be prioritised over food imports under a no-deal Brexit, the Health Secretary has declared. Matt Hancock said it was necessary move as half of drugs currently used in…

Read More Here

Brexit means end of European work for evaluation of new medicines for sale across EU

Britain’s leading role in evaluating new medicines for sale to patients across the EU has collapsed with no more work coming from Europe because of Brexit, it has emerged. The decision by…

Read More Here